PO.CL05.13 · 临床研究
Vaccines and Other Immunomodulatory Agents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- 6707 6707 开发表达 MG53 的溶瘤麻疹病毒用于肺癌治疗 Developing oncolytic measles virus expressing MG53 for the treatment of lung cancer Zhongguang Li, Cheng Chih Hsu, Fei Jiang, Matthew Bu, Ellica Leong, Umme Lubaba, Xuefeng Liu, Jianrong Li, Haichang Li
-
-
- 6710 6710 开发激活T细胞的核酸融合疫苗以预防转移性葡萄膜黑色素瘤的建立 Development of T cell activating nucleic acid fusion vaccine to prevent metastatic uveal melanoma establishment Vitali Alexeev, Mizue Terai, Sergei Koshkin, Takami Sato
-
- 6712 6712 利用表达双特异性巨噬细胞接合器的溶瘤腺病毒促进肿瘤抗原的非特异性交叉呈递 Promoting improved agnostic cross presentation of tumor antigens with an oncolytic adenovirus expressing bispecific macrophage engagers Ahmet Hazini, Margarida Rei, Natanya Cartwright, Ricardo A. Fernandes, Kerry Fisher, Len Seymour
-
-
- 6715 6715 HER2多表位疫苗联合T-DM1治疗残留HER2阳性乳腺癌的安全性导入阶段的安全性、耐受性及早期免疫应答 Safety, tolerability, and early immune responses in the safety run-in of an HER2 multi-epitope vaccine combined with T-DM1 in residual HER2-positive breast cancer Saranya Chumsri, Sharmila Giri, Andy J. Ness, David W. Hillman, Nadine Norton, Davitte Cogen, Brian M. Necela, Aziza Nassar, Donald W. Northfelt, Pooja Advani, Rohit Rao, Alvaro Mareno-Aspitia, Brenda Ernst, Kathryn J. Ruddy, Matthew P. Goetz, Keith L. Knutson
-
-
-
